Goodbye To Snail Mail: FDA Endorses E-mail For Sending Recall Notices
This article was originally published in The Pink Sheet Daily
Final guidance acknowledges that e-mail is less expensive, faster and more likely to be read than traditional letters.
You may also be interested in...
Device center ombudsman Weinstein refers Cardima to the DRP regarding a 2002 application.
Communications addressed to ombudsman of FDA's device center drop to three-year low of 114, according to 2005 report.
Among the 275 applications for combination products submitted were 12 NDAs, 152 INDs and two BLAs.